U.S. Senate Questioning Safety of Glaxo's Avandia Drug: Video
574 views · Published 23 March 2012 · 2:10 · Indexed 29 September 2026
Channel: Bloomberg Originals · 2012 · Entertainment
Feb. 22 (Bloomberg) -- Bloomberg's Peter Cook reports on GlaxoSmithKline Plc's Avandia diabetes-treatment drug. Shares of the drugmaker fell after U.S. Senators released a report showing that safety reviewers had urged the U.S. Food and Drug Administration to take Avandia off the market because it caused an increased risk of heart attacks. (Source: Bloomberg)
More from this channel
-
3:30
Market Close 6.4 - Bloomberg
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg